187 related articles for article (PubMed ID: 28038473)
21. Prognostic value of cell motility activation factors in patients with tongue squamous cell carcinoma.
Endo K; Shirai A; Furukawa M; Yoshizaki T
Hum Pathol; 2006 Aug; 37(8):1111-6. PubMed ID: 16867875
[TBL] [Abstract][Full Text] [Related]
22. Bioinformatics analysis and validation of HAUS6 as a key prognostic gene in squamous cell carcinoma of the tongue.
Yao Z; Chen J; Wang Y; Cao L
Arch Oral Biol; 2024 Aug; 164():106000. PubMed ID: 38759391
[TBL] [Abstract][Full Text] [Related]
23. The prognostic value of hypoxia markers in T2-staged oral tongue cancer.
Roh JL; Cho KJ; Kwon GY; Ryu CH; Chang HW; Choi SH; Nam SY; Kim SY
Oral Oncol; 2009 Jan; 45(1):63-8. PubMed ID: 18620902
[TBL] [Abstract][Full Text] [Related]
24. Quantitative expression analysis of the apoptosis-related gene, BCL2L12, in head and neck squamous cell carcinoma.
Geomela PA; Kontos CK; Yiotakis I; Scorilas A
J Oral Pathol Med; 2013 Feb; 42(2):154-61. PubMed ID: 22747515
[TBL] [Abstract][Full Text] [Related]
25. Survivin gene polymorphism association with tongue squamous cell carcinoma.
Mostaan LV; Tabari A; Amiri P; Ashtiani MK; Mahdkhah A; Yazdani N; Khaniki M; Tabari A; Tavakkoly-Bazzaz J; Amoli MM
Genet Test Mol Biomarkers; 2013 Jan; 17(1):74-7. PubMed ID: 23176035
[TBL] [Abstract][Full Text] [Related]
26. Altered DNA methylation is associated with aberrant stemness gene expression in early‑stage HNSCC.
Suzuki T; Yamazaki H; Honda K; Ryo E; Kaneko A; Ota Y; Mori T
Int J Oncol; 2019 Oct; 55(4):915-924. PubMed ID: 31432153
[TBL] [Abstract][Full Text] [Related]
27. Overexpression of Kif2a promotes the progression and metastasis of squamous cell carcinoma of the oral tongue.
Wang CQ; Qu X; Zhang XY; Zhou CJ; Liu GX; Dong ZQ; Wei FC; Sun SZ
Oral Oncol; 2010 Jan; 46(1):65-9. PubMed ID: 20005768
[TBL] [Abstract][Full Text] [Related]
28. High expression of serine protease inhibitor kazal type 1 predicts poor prognosis and promotes the progression and invasion of oral tongue squamous cell carcinoma.
Wang S; Sun Y; Shao D; Pan Y; Gao X; Zhao P; Liu Q; Shang G; Shang W; Fu Z; Sun Y
Arch Oral Biol; 2024 Aug; 164():106003. PubMed ID: 38781741
[TBL] [Abstract][Full Text] [Related]
29. Bmi-1 expression predicts prognosis in squamous cell carcinoma of the tongue.
Häyry V; Mäkinen LK; Atula T; Sariola H; Mäkitie A; Leivo I; Keski-Säntti H; Lundin J; Haglund C; Hagström J
Br J Cancer; 2010 Mar; 102(5):892-7. PubMed ID: 20145620
[TBL] [Abstract][Full Text] [Related]
30. Expressions of ezrin, ERK, STAT3, and AKT in tongue cancer and association with tumor characteristics and patient survival.
Noi M; Mukaisho KI; Murakami S; Koshinuma S; Machida Y; Yamori M; Nakayama T; Ogawa T; Nakata Y; Shimizu T; Yamamoto G; Sugihara H
Clin Exp Dent Res; 2020 Aug; 6(4):420-427. PubMed ID: 32281236
[TBL] [Abstract][Full Text] [Related]
31. The downregulation of ANGPTL4 inhibits the migration and proliferation of tongue squamous cell carcinoma.
Huang Z; Xie J; Lin S; Li S; Huang Z; Wang Y; Ye J
Arch Oral Biol; 2016 Nov; 71():144-149. PubMed ID: 27505034
[TBL] [Abstract][Full Text] [Related]
32. MiR-21 indicates poor prognosis in tongue squamous cell carcinomas as an apoptosis inhibitor.
Li J; Huang H; Sun L; Yang M; Pan C; Chen W; Wu D; Lin Z; Zeng C; Yao Y; Zhang P; Song E
Clin Cancer Res; 2009 Jun; 15(12):3998-4008. PubMed ID: 19509158
[TBL] [Abstract][Full Text] [Related]
33. Significance of galectins-1, -3, -4 and -7 in the progression of squamous cell carcinoma of the tongue.
Alves PM; Godoy GP; Gomes DQ; Medeiros AM; de Souza LB; da Silveira EJ; Vasconcelos MG; Queiroz LM
Pathol Res Pract; 2011 Apr; 207(4):236-40. PubMed ID: 21397408
[TBL] [Abstract][Full Text] [Related]
34. Caveolin-1 accumulation in the tongue cancer tumor microenvironment is significantly associated with poor prognosis: an in-vivo and in-vitro study.
Vered M; Lehtonen M; Hotakainen L; Pirilä E; Teppo S; Nyberg P; Sormunen R; Zlotogorski-Hurvitz A; Salo T; Dayan D
BMC Cancer; 2015 Jan; 15():25. PubMed ID: 25633184
[TBL] [Abstract][Full Text] [Related]
35. EMMPRIN expression in tongue squamous cell carcinoma.
Huang Z; Huang H; Li H; Chen W; Pan C
J Oral Pathol Med; 2009 Jul; 38(6):518-23. PubMed ID: 19473445
[TBL] [Abstract][Full Text] [Related]
36. Vascular endothelial growth factor C (VEGF-C) expression predicts metastasis in tongue cancer.
Matsui T; Shigeta T; Umeda M; Komori T
Oral Surg Oral Med Oral Pathol Oral Radiol; 2015 Oct; 120(4):436-42. PubMed ID: 26216169
[TBL] [Abstract][Full Text] [Related]
37. High expression of EPB41L5, an integral component of the Arf6-driven mesenchymal program, correlates with poor prognosis of squamous cell carcinoma of the tongue.
Otsuka Y; Sato H; Oikawa T; Onodera Y; Nam JM; Hashimoto A; Fukunaga K; Hatanaka KC; Hatanaka Y; Matsuno Y; Fukuda S; Sabe H
Cell Commun Signal; 2016 Nov; 14(1):28. PubMed ID: 27871329
[TBL] [Abstract][Full Text] [Related]
38. Mitochondrial assembly receptor expression is an independent prognosticator for patients with oral tongue squamous cell carcinoma.
Su YY; Chen CH; Chien CY; Lin WC; Huang WT; Li SH
J Renin Angiotensin Aldosterone Syst; 2017; 18(3):1470320317717904. PubMed ID: 28747140
[TBL] [Abstract][Full Text] [Related]
39. Metallothionein expression in mobile tongue squamous cell carcinoma: associations with clinicopathological parameters and patient survival.
Theocharis S; Klijanienko J; Giaginis C; Rodriguez J; Jouffroy T; Girod A; Point D; Tsourouflis G; Sastre-Garau X
Histopathology; 2011 Sep; 59(3):514-25. PubMed ID: 22034891
[TBL] [Abstract][Full Text] [Related]
40. Vimentin is a potential prognostic factor for tongue squamous cell carcinoma among five epithelial-mesenchymal transition-related proteins.
Liu PF; Kang BH; Wu YM; Sun JH; Yen LM; Fu TY; Lin YC; Liou HH; Lin YS; Sie HC; Hsieh IC; Tseng YK; Shu CW; Hsieh YD; Ger LP
PLoS One; 2017; 12(6):e0178581. PubMed ID: 28570699
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
